U
Navidea Biopharmaceuticals, Inc. NAVB
$0.0001 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Net Income -- 508.58% 57.61% 38.99% -90.29%
Total Depreciation and Amortization -- -1.81% 4.15% 7.29% 13.30%
Total Amortization of Deferred Charges -- 14.10% 14.25% 14.14% 25.80%
Total Other Non-Cash Items -- 114.12% -575.10% 129.74% 13.77%
Change in Net Operating Assets -- -309.80% 11.15% -80.78% 428.91%
Cash from Operations -- 372.37% 29.22% -30.95% 13.15%
Capital Expenditure -- 100.00% -- 100.00% -118.18%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -168.72% 66.25% -11.63% 43.72%
Cash from Investing -- -64.97% 45.28% 8.75% 34.90%
Total Debt Issued -- -- -- -100.00% -33.33%
Total Debt Repaid -- -151.62% -209.89% -- 100.00%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -100.00% --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 96.36% -6,497.95%
Cash from Financing -- 840.45% -100.90% -101.61% 352.80%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -- 411.41% 24.68% -160.96% 580.58%
Weiss Ratings